Development of Thrombocytopenia and Survival Outcomes in Newly Diagnosed Multiple Myeloma

被引：1

作者：

Mellors, Patrick ^{[1
]}

Binder, Moritz ^{[2
]}

Buadi, Francis K. ^{[2
]}

Lacy, Martha Q. ^{[2
]}

Gertz, Morie A. ^{[2
]}

Dispenzieri, Angela ^{[2
]}

Hayman, Suzanne R. ^{[2
]}

Kapoor, Prashant ^{[2
]}

Gonsalves, Wilson I. ^{[2
]}

Hwa, Yi ^{[2
]}

Fonder, Amie ^{[2
]}

Hobbs, Miriam ^{[2
]}

Kourelis, Taxiarchis ^{[2
]}

Warsame, Rahma ^{[2
]}

Zeldenrust, Steven ^{[2
]}

Lust, John A. ^{[2
]}

Leung, Nelson ^{[2
]}

Go, Ronald S. ^{[2
]}

Kyle, Robert A. ^{[2
]}

Rajkumar, S. Vincent ^{[2
]}

Kumar, Shaji K. ^{[2
]}

机构：

[1] Mayo Clin, Dept Internal Med, Rochester, MN USA

[2] Mayo Clin, Div Hematol, Rochester, MN USA

来源：

BLOOD | 2018年 / 132卷

关键词：

D O I：

10.1182/blood-2018-99-112138

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1902

引用

页数：3

共 50 条

[41] Clinical Features and Survival Outcomes in Diabetic Patients with Newly Diagnosed Multiple Myeloma (NDMM) Enrolled in the Connect® MM Registry
La, Lisa
Jagannath, Sundar
Ailawadhi, Sikander
Durie, Brian G. M.
Gasparetto, Cristina J.
Hardin, James W.
Lee, Hans C.
Narang, Mohit
Omel, James L.
Rifkin, Robert M.
Terebelo, Howard R.
Toomey, Kathleen
Wagner, Lynne I.
Dhalla, Mazaher
Liu, Liang
Yang, Ling
Joshi, Prashant
Abonour, Rafat
BLOOD, 2020, 136
[42] Fixed Duration Daratumumab, Ixazomib, Lenalidomide, and Dexamethasone Quadruplet for Newly Diagnosed Multiple Myeloma - MRD Negativity and Survival Outcomes
Kumar, Shaji K.
Laplant, Betsy
Asmus, Erik J.
Buadi, Francis K.
Gonsalves, Wilson, I
Muchtar, Eli
Dingli, David
Thompson, Melanie Ann
Go, Ronald
Warsame, Rahma M.
Kourelis, Taxiarchis
Hwa, Yi L.
Fonder, Amie
Hobbs, Miriam A.
Lacy, Martha Q.
Dispenzieri, Angela
Hayman, Suzanne R.
Leung, Nelson
Binder, Moritz
Rajkumar, S. Vincent
Gertz, Morie A.
Kapoor, Prashant
BLOOD, 2022, 140 : 10142 - 10143
[43] Optimising bortezomib in newly diagnosed multiple myeloma
Rajkumar, S. Vincent
LANCET ONCOLOGY, 2010, 11 (10): : 909 - 910
[44] Oprozomib in patients with newly diagnosed multiple myeloma
Hari, Parameswaran
Matous, Jeffrey V.
Voorhees, Peter M.
Shain, Kenneth H.
Obreja, Mihaela
Frye, John
Fujii, Hisaki
Jakubowiak, Andrzej J.
Rossi, Davide
Sonneveld, Pieter
BLOOD CANCER JOURNAL, 2019, 9 (9)
[45] Cytogenetics in newly diagnosed multiple myeloma.
Testoni, N
Ruggeri, D
Tosi, P
Carboni, C
Iacurti, E
Martinelli, G
Ronconi, S
Cavo, M
Tura, S
BLOOD, 1999, 94 (10) : 306B - 306B
[46] NEW TREATMENTS FOR NEWLY DIAGNOSED MULTIPLE MYELOMA
Terpos, Evangelos
LEUKEMIA RESEARCH, 2016, 49 : S15 - S15
[47] Consolidation and Maintenance in Newly Diagnosed Multiple Myeloma
Sonneveld, Pieter
Dimopoulos, Meletios A.
Beksac, Meral
van der Holt, Bronno
Aquino, Sara
Ludwig, Heinz
Zweegman, Sonja
Zander, Thilo
Zamagni, Elena
Wester, Ruth
Hajek, Roman
Pantani, Lucia
Dozza, Luca
Gay, Francesca
Cafro, AnneMaria
De Rosa, Luca
Morelli, Annamaria
Gregersen, Henrik
Gulbrandsen, Nina
Cornelisse, Petra
Troia, Rosella
Oliva, Stefania
van de Velden, Vincent
Wu, KaLung
Ypma, Paula F.
Bos, Gerard
Levin, Mark-David
Pour, Luca
Driessen, Christoph
Broijl, Annemiek
Croockewit, Alexandra
Minnema, Monique C.
Waage, Anders
Hveding, Cecilie
van de Donk, Niels W. C. J.
Offidani, Massimo
Palumbo, Giuseppe A.
Spencer, Andrew
Boccadoro, Mario
Cavo, Michele
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (32) : 3613 - +
[48] Setting the standard for newly diagnosed multiple myeloma
Jacob Laubach
Paul G. Richardson
Kenneth Anderson
Nature Reviews Clinical Oncology, 2011, 8 : 255 - 256
[49] Clinical treatment of newly diagnosed multiple myeloma
Cejalvo, Maria J.
de la Rubia, Javier
EXPERT REVIEW OF HEMATOLOGY, 2015, 8 (05) : 595 - 611
[50] Management of multiple myeloma in the newly diagnosed patient
Mateosi, Maria-Victoria
San Miguel, Jesus F.
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2017, : 498 - 507

← 1 2 3 4 5 →